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Abstract
We have established an in vitro replication system for bovine viral diarrhea virus (BVDV), a surrogate for the closely-related hepatitis
C virus. In an in vitro reaction, BVDV replication complexes synthesize vRNA and replicative form (RF) and replicative intermediate (RI)
RNAs. Kinetic and heparin trapping experiments demonstrate the recycling of RF and RI products and the initiation of vRNA synthesis in
this system. Consistent with this, quantitative hybridization reveals the asymmetric synthesis of positive and negative strand RNA products.
These findings support the notion that RF serves as a template and RI as a precursor in the synthesis of vRNA. Furthermore, the antiviral
activity of an NS5B inhibitor was similar in BVDV replicase and infectivity assays. Together, these results indicate that the in vitro activity
of BVDV replicase complexes recapitulates RNA replication that occurs in infected cells, providing a system in which to study both
mechanisms and inhibitors of Flaviviridae replication.
© 2003 Elsevier Science (USA). All rights reserved.
Keywords: Bovine viral diarrhea virus (BVDV); Replication complexes; Flaviviridae
Introduction
Bovine viral diarrhea virus (BVDV) is a positive strand
RNA virus and one of the best studied pestiviruses within
the Flaviviridae family (Lindenbach and Rice, 2001). It
represents an attractive model system to characterize the
replication of the closely related hepacivirus, hepatitis C
virus (HCV), a major cause of hepatitis and chronic liver
disease for which an infectious cell culture system does not
exist (Lindenbach and Rice, 2001). The viral genomes of
BVDV and HCV encode single polyproteins, which are
processed cotranslationally by viral and cellular proteases,
yielding several functionally conserved gene products.
These are the nucleocapsid protein, C, three virion glyco-
proteins Erns, E1, and E2, and several genes encoding en-
zymatic functions and structural components of the replica-
tion complex, including NS2-NS3 (helicase/protease)-NS4A-
NS4B-NS5A-NS5B (polymerase)-COOH. Additionally, cis-
acting elements located within the nontranslated regions
which regulate the translation and replication of HCV and
BVDV can be functionally substituted, further suggesting
that the viruses share similar replication strategies (Frolov et
al., 1998). Thus, comparative studies will aid in the search
for antiviral agents.
The replication of BVDV has been characterized in in-
fected cells and is predicted to be similar to that of other
positive strand RNA viruses which occurs in membrane-
associated complexes localized to the endoplasmic reticu-
lum (Gong et al., 1996, 1998). Replication is postulated to
proceed first through the synthesis of a negative strand copy
of genomic RNA which produces a double-stranded (ds)
replicative form (RF) containing the input positive strand
RNA. The resulting RF then serves as a template for the
synthesis of numerous copies of positive strand RNA,
which comprises a structure known as the replicative inter-
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mediate (RI) containing associated nascent plus strand mol-
ecules, and supports the asymmetric replication of viral
RNA (Racaniello, 2001).
The replication of positive strand RNA viruses has also
been studied in vitro using crude replication complexes
(CRCs), which catalyze the synthesis of viral RNA in in-
fected cells. Although the precise composition of replication
complexes is unknown, complexes isolated from infected
cells contain replicative intermediate RNA, newly synthe-
sized vRNA, and several viral proteins including an RNA-
dependent RNA polymerase, helicase, and proteinases
(Bienz et al., 1992; Egger et al., 1996; Grassman et al.,
1999; Westaway et al., 1999). When reconstituted in in vitro
reactions, the complexes synthesize full-length vRNA, RI,
and RF products, resembling those identified in infected
cells (Chu and Westaway, 1987, 1992; Grun and Brinton,
1986; Warrilow et al., 2000). Additionally, strand-specific,
protein-primed (VPg) initiation of RNA synthesis was dem-
onstrated for poliovirus replication complexes and more
recently picornavirus replication has been elucidated in an
vitro reaction, in which RNA synthesis is de novo initiated
by VPg (3B), following its nucleotidylyation by the 3D
polymerase (Paul et al., 2000; Reider et al., 2000; Takeda et
al., 1986; Takegami et al., 1983). Replication complexes
have also been isolated for the West Nile, Kunjin, and
BVDV viruses (Chu and Westaway, 1987; Grun and Brin-
ton, 1986; Warrilow et al., 2000) and while RNA products
similar to those observed in infected cells are synthesized,
the mechanisms involved in the RNA replication of these
viruses are still largely unknown.
Detailed biochemical analysis of the polymerase activity
of positive strand RNA viruses has been performed using
recombinant polymerases (Behrens, et al., 1996; Carroll et
al., 2000; Lai et al., 1999; Neufeld et al., 1991; Zhong et al.,
1998). However, these studies have indicated that the in
vitro activity of the recombinant polymerases is character-
istically different from replication observed in vivo or in
isolated complexes. For example, reactions containing only
the 3D polymerase of poliovirus, expressed and purified
from either bacterial or insect cells, are capable of elongat-
ing template and/or primed template pairs; however, the
enzyme will copy templates of heterologous, nonviral se-
quence (Arnold et al., 1999). Similarly, the NS5B poly-
merases of BVDV and HCV have been shown to synthesize
RNA in vitro from heterologous templates, although a mode
of de novo initiation has been demonstrated for both en-
zymes (Hong et al., 2001; Kao et al., 1999; Luo et al., 2000;
Ranjith-Kumar et al., 2002). Therefore, it appears that either
additional viral replicative proteins are required or a mem-
brane environment and/or cellular factor(s) is involved in
conferring specificity to RNA replication.
As a means to elucidate BVDV RNA replication, we
have isolated fractions containing replication complexes
from infected cells. When reconstituted in an in vitro sys-
tem, optimal for the synthesis of genomic-length vRNA,
RF, and RI products, RNA replication characteristic of that
observed during viral infection is exemplified (Gong et al.,
1996). Kinetic studies demonstrate the sequential synthesis
and recycling of RF and RI products, suggesting that these
RNAs functionally serve as template and precursor, respec-
tively, in vRNA synthesis. In line with this, heparin trapping
experiments and quantitative hybridization of replicase
products reveal that this system is capable of the initiation
of RNA synthesis and the asymmetric synthesis of positive
and negative strand RNAs. Notably, the inhibition of
BVDV replicase by a small molecule with a potency similar
to that observed in viral infection indicates that the activity
of the isolated complexes directly reflects the catalysis of
RNA synthesis in infected cells. This system will prove
useful in delineating the mechanisms and inhibition of RNA
replication of BVDV and other members of the Flaviviridae
family.
Results
Isolation and assay of BVDV replication complexes
To study the in vitro replication of BVDV RNA, subcel-
lular fractions containing replication complexes were iso-
lated from MDBK cells infected with the NADL strain,
using methods similar to those previously described for
other positive strand viruses (Grun and Brinton, 1986;
Takegami et al., 1983). Following fractionation, the tran-
scriptional activity of the various subcellular fractions was
assayed in a reaction containing [32P]CTP, nucleotide
triphosphates (NTPs), actinomycin D (act D), and an ATP-
regenerating system. The resulting RNA products synthe-
sized in the presence of CRC and perinuclear supernatant
(PNS) fractions isolated from infected, but not from equiv-
alent fractions of mock infected cells, specifically hybrid-
ized to cDNA probes representing the structural and non-
structural (NS2/3 and NS4/5) regions of the BVDV genome
(Fig. 1A). Enrichments of 4.4- and 1.6-fold in replicase
activity and recoveries of 63 and 26% of total activity were
obtained in the CRC and PNS fractions, respectively, with
little activity remaining in the postcytoplasmic extract (Fig.
1A and Table 1). A greater specific activity was routinely
observed in the CRC fraction relative to the PNS fraction
and was subsequently pursued as the enzyme source for
RNA synthesis (Table 1).
The RNA transcripts present in the hybridizable fractions
migrated with a mobility of less than or equal to the size of
full-length vRNA (12.5 kb) on totally denaturing agarose
gels (Fig. 1B). Larger molecular weight products, ca. 24 kb
in size, were also present and were deduced to be dsRI/RF
products by denaturation and RNase sensitivity studies (data
not shown). As shown in Fig. 1B and C, the reaction was
linear during a 90-min period and optimal activity was
obtained at 35°C in the presence of 500 M concentra-
tions of A and GTP. Synthesis was detected only in the
presence of all four NTPs and not in the presence of each
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single, radiolabeled nucleotide, indicating that terminal
transferase activity does not contribute to the reaction (data
not shown).
Protein content of the isolated BVDV replication
complexes
Western blot analysis revealed that the nonstructural
proteins (NS2, NS3, NS4A, NS4B, and NS5B) are present
in the CRC and PNS fractions isolated from BVDV in-
fected, but not from equivalent fractions of mock infected
cells. An antibody was not available to test for NS5A. As
shown in Fig. 2, the fully processed forms of the nonstruc-
tural proteins were detected. When probed with the anti-
NS3 antibody, in addition to the NS3 protein (71 kDa),
presumably full-length and NS2-3 precursors220 and 125
kDa, respectively, were observed. Probing with anti-NS2
resulted in a strong detection of NS2 but minimal detection
of the 125-kDa NS2-3 precursor, potentially due to poorer
recognition of the uncleaved C terminal region with this
antibody. The reason for the doublet which reproducibly
appears when probed with anti-NS4A antibody is unclear
and may be attributed to aberrant cleavage and/or proteo-
lytic degradation. Cellular proteins were also observed in
Fig. 1. Specificity and synthesis of RNA transcripts by BVDV CRC. (A) Subcellular fractions (1.25  106 ceq) isolated from mock (M) or BVDV infected
(1) MDBK cells at 48 h postinfection were assayed in an in vitro RNA synthesis reaction as described under Materials and methods. Following purification,
RNA products were then were hybridized to the indicated BVDV cDNAs (structural, nts 3275–4600; NS2/3, nts 4655–8652; NS4/5, nts 8666–12573),
immobilized on nitrocellulose, autoradiographed, and quantitated by phosphorimager analysis. (B) RNA transcripts were synthesized in the presence of
[32P]-CTP by BVDV CRC (6.25 105 ceq) at the indicated times, purified, and electrophoresed on 0.7% agarose–glyoxal denaturing gels. (C) RNA products
in the gel in B were quantitated by phosphorimager analysis and plotted as a function of time.
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stained protein gels of replicase complexes (data not
shown).
Polarities of the RNA products synthesized by BVDV
replication complexes
The polarities of the endogenous complex RNA and the
products synthesized were determined by a ribonuclease
protection assay (RPA). The specificity of the RPA and
copy numbers were determined from positive and negative
strand transcripts assayed in parallel in varying amounts
(data not shown). As shown in Fig. 3A and in Table 2, a
9-fold greater amount of positive than negative strand RNA
was detected in the isolated CRCs, referred to as time zero
(t  0), which was estimated to be approximately 6500
copies of positive strand and 750 copies of negative strand
RNA per cell equivalent (ceq). Following synthesis for 60
min, a 4.7-fold increase in positive strand and a 2-fold
increase in negative strand RNA was observed which cor-
responds to 24,520 and 809 copies synthesized per cell
equivalent, respectively, indicating that amplification of
both strands occurred. The total amount of product RNA
quantitated per reaction, ca. 3.16 1010 copies or 216 ng of
RNA, is comparable that detected by TCA precipitation
(Table 1).
Increases in positive and negative strand RNA products
were also detected by Northern blot analysis (Fig. 3B).
When probed with antisense 5 and 3 NTR probes, in-
creases of 4.4- and 2.9-fold were observed for positive stand
RNA, respectively, and increases of 1.5- and 2.8-fold were
observed for negative strand RNA when probed with sense
5 and 3 NTR probes (Fig. 3C). Note that higher amounts
of RNA were detected using probes that recognized the 5
ends of each RNA. Similarly, RT-mediated PCR of repli-
case products using 5 NTR primers and quantitation fol-
lowing Southern blot transfer indicated that positive and
negative strand RNAs were present in the CRC fraction at
time 0, and at 60 min increases of 6-fold in positive strand
and 2-fold in negative strand RNA were observed (data not
shown).
Synthesis of RI, RF, and vRNA products by BVDV
replication complexes
To delineate the strandedness of the RNA products, a
partially denaturing gel system was used, in which only
single-stranded (ss) RNAs are denatured and the replication
products separate as RI, vRNA, and RF on 3% polyacryl-
amide (PAGE)–7 M urea gels (Chu and Westaway, 1985).
The identities of these RNA species were verified on the
basis of LiCl separation and RNase sensitivities wherein
mainly dsRNA (RI and RF) was detected in the supernatant
fraction of LiCl precipitated replicase products, while an
enrichment of ss vRNA was observed in the precipitate (Fig.
4). Correspondingly, RNase A/T1digestion of the RNA
products under high salt conditions resulted in preferential
degradation of ss vRNA and partially ssRI, and all products
were totally degraded under low salt conditions.
Kinetics and sequence of RNA product synthesis
The sequence of the synthesis of RNA products was
determined by continuous labeling in the in vitro replicase
reaction. As shown in Fig. 5A, the greatest labeling oc-
curred first in the RI product, followed by RF and vRNA
(Fig. 5A). Although the labeling of RF was linear through-
out the reaction time course, the labeling of RI was initially
linear but then plateaued and slightly decreased (Fig. 5B). A
peak of vRNA which was routinely observed at 5 min
Table 1
Replicase activity in subcellular fractions of BVDV infected MDBK
cells
Fraction Activity
(ng/(g/h))a
Relative
activityb
Total (ng)
product
% Total
activityc
Total homogenate 2.5 1.0 nd nd
Cytoplasmic extract 3.1 1.5 nd nd
CRC 11.0 4.4 321 63
Postcytoplasmic extract 1.9 0.8 58 11
PNS 4.1 1.6 129 26
a Expressed as nanograms of TCA precipitable product RNA per micro-
gram of total protein from a 50-l reaction containing 1.25  106 ceq of
each fraction.
b Compared to total cell homogenate.
c Total in recovered fractions.
Fig. 2. Western blot analysis of BVDV CRC and PNS fractions. CRC and
PNS fractions (1.25  106 ceq) isolated from mock and BVDV infected
cells were electrophoresed on 10% Bis–Tris Nupage (Novex) gels in MES
or Mops buffer then transferred to nitrocellulose and Western blotted with
the indicated anti-peptide polyclonal sera as described under Materials and
methods. Arrows indicate protein positions.
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disappeared at 10 min, but then reappeared at 20 min and
linearly increased thereafter. As the labeling of RI de-
creased, the labeling of vRNA increased, indicating the
release of vRNA from the RI. Notably, the increase in RF
labeling correlated with an increase in vRNA and a decrease
in RI product, suggesting the recycling of RI to RF.
To further determine whether the initiation of RNA syn-
thesis and template recycling occur in this system, pulse
labeling of RNA products was performed at the indicated
times as outlined in the legend to Fig. 5C. In this way, RNA
transcripts are elongated in the absence of label, and then
RNA synthesis is pulsed for short periods with labeled
nucleotide. As shown in Fig. 5C and D, apart from its
absence at 10 and 60 min, vRNA was synthesized through-
out the reaction, indicating that following elongation and
release of nascent transcripts, initiation likely occurs. Con-
sistent with this, the labeling of RI decreased only slightly
over time, whereas RF decreased significantly and, by 60
min, the ratio of RI to RF labeling was 1:1, compared to
ratios of 0.3–0.5:1 observed earlier in the reaction. This
pattern of early labeling of RI followed by a slow decrease
is similar to that seen in the continuous labeling time course
(Fig. 5B). However, the pulse labeling of RF decreased in
contrast to the linear increase observed during the time
course labeling, indicating that the increase in RF labeling is
attributed at least in part to the recycling of RF from RI
Fig. 3. Polarity of the reaction products. (A) RNA products were purified following synthesis of mock and BVDV CRC replicase fractions (1.25  106 ceq)
in an in vitro reaction at 0 or 60 min as described under Materials and methods in the absence of [32P]CTP. The RNA was subjected to RPA using the indicated
probes according to the procedure specified in the RPA II kit (Ambion, Inc.) at a level of 1:100 RNase A/T1 for 20 min at 37°C and then electrophoresed
on a 5% polyacrylamide–8 M urea gel and quantitated by phosphorimager analysis. (B) Replicase products isolated at the indicated times were probed with
32P-labeled 5 and 3 NTR probes as described under Materials and methods on Northern blots following transfer from glyoxal gels. (C) RNA products in
Northern blot of B were quantitated on a phosphorimager and plotted.
Table 2
Number of BVDV genomes in replicase complexes per cell determined
by RPA
BVDV copies/ceqa Ratio
Time (min) Positive strand Negative strand (/) strands
0 6539 590 750  351 9.0
60 31,059 9660 1559  596 20.0
Total copy number 24,520 9070 809  245
Fold increaseb 4.7 2.0
a The number of copies of BVDV RNA was determined from control
transcripts run in parallel and are the results of three separate determina-
tions as described in Fig. 3.
b Fold increase in copies obtained at 60 min compared to zero time.
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following the displacement of vRNA, rather than accumu-
lative synthesis.
Effect of heparin upon RNA synthesis
To confirm that initiation is occurring in the replicase
reaction, the effect of a polymerase trapping reagent was
determined. As seen in Fig. 6A and B, RNA synthesis was
inhibited during a time course of labeling performed in the
presence of heparin [2 mg/ml] compared to synthesis in its
absence, further indicating that the in vitro system is capable
of initiating synthesis. The most pronounced heparin effect
was observed upon vRNA synthesis, with inhibitions of
50% observed at 10 min and 65% at 60 min. Additionally in
the presence of heparin, after 20 min the synthesis of RI and
RF was inhibited and at 60 min 49 and 39% inhibitions were
observed, respectively. Enhanced labeling of RI and RF was
also observed at 5–20 min and may represent the inhibition
of vRNA release.
Sensitivity of BVDV replicase to an inhibitor of NS5b and
replication
The effect of compound 1, a triazinoindole previously
reported to inhibit BVDV replication and NS5b polymerase,
was tested in the BVDV in vitro replicase assay (Baginski et
al., 2000). The compound elicited a dose-dependent effect
upon RNA synthesis by BVDV replicase with an IC50 of 37
nM (Fig. 7A). Similar to the inhibitory activities previously
reported, in a single cycle infectivity assay in MDBK cells,
the compound had an IC50 of 80 nM when measured by in
situ RPA in the absence of cytotoxicity and was also active
in an NS5b assay with an IC50 of 800 nM (Fig. 7B).
Discussion
In an effort to elucidate the mechanisms of BVDV RNA
replication, we have investigated the transcriptional activity
of replication complexes isolated from infected cells. Al-
though the in vitro properties of BVDV replicase have been
previously reported (Warrilow et al., 2000), we herein
present an extensive study using an in vitro system opti-
mized for the synthesis of vRNA, RI, and RF products, in
which the sequence and recycling of RNA products, the
initiation of RNA synthesis, and the asymmetric synthesis
of positive and negative strand RNA products are demon-
strated.
Similar to the replication complexes isolated from mem-
branes of cells infected with positive strand RNA viruses,
subcellular fractions containing BVDV complexes are
found to contain the viral nonstructural proteins (NS2–5B).
Positive and negative strand BVDV RNAs are present in the
isolated complexes in a ratio of 9:1, respectively, compara-
ble to the 10:1 asymmetry observed in infected cells at 12 to
18 h pi (Gong et al., 1996, 1998). Approximately 6500
copies of positive strand and 750 copies of negative strand
RNA are detected in the complex per cell equivalent iso-
lated in the CRC fraction, which is roughly 50–60% of the
total viral RNA (ca. 1.5–2.0  104 copies) in an infected
cell (Gong et al., 1996, and R. LaFemina, unpublished
observations). Upon cell fractionation, 63 and 26% of the
replicase activity is recovered in the CRC and PNS frac-
tions, respectively, and thus the majority of vRNA in in-
fected cells can be accounted for in these membranous
fractions (Fig. 1, Table 1).
When reconstituted in an in vitro reaction, fractions con-
taining BVDV replication complexes synthesize vRNA, RI,
and RF products, reminiscent of those observed in infected
cells (Gong et al., 1996). Despite the presence of cellular
proteins in the complexes, replicase activity is specific and
distinct from that of terminal transferase and/or other cel-
lular enzymes, since RNA synthesis occurs only in reactions
containing replicase isolated from infected cells in the pres-
ence of all four NTPs. Unlike the previously reported in
vitro system (Warrilow et al., 2000), the synthesis of ss
vRNA is robust and reproducible, likely attributed to dif-
ferences in reaction conditions. Optimal transcription of
vRNA, RI, and RF products is observed at 35°C, in the
presence of KCl (25–50 mM), Mg2 (2–5 mM), and high
concentrations (500 M) of the nucleotides ATP and
GTP. The importance of GTP has been implicated previ-
ously in the de novo initiation of RNA synthesis by BVDV
NS5B polymerase (Kao et al., 1999; Ranjuith-Kumar et al.,
2002) and, correspondingly, RNA synthesis is not observed
in this system at 80 M of GTP (data not shown). The
synthesis of full-length vRNA is ATP-dependent. In the
Fig. 4. Analysis of RNA products on semi-denaturing gels. RNA products
were purified following in vitro synthesis of CRC replicase (6.25  105
ceq) isolated from mock or BVDV infected MDBK cells in the presence of
[32P]CTP for 60 min. Products were fractionated by LiCl precipitation or
treated with Rnase A/T1 then electrophoresed on a 3% PAGE–7 M urea
gel. Lane 1, mock infected MDBK cells; lane 2, no LiCl fractionation; lane
3, LiCl supernatant; lane 4, LiCl precipitate; lane 5, digestion with 0 units
of RNAse A/T1 in high salt; lane 6, digestion with 100 units in high salt;
lane 7, digestion with 200 units in high salt or in low salt, lane 8.
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absence of an ATP regenerating system and 80 M of
ATP, RI and RF but not vRNA products are visible on
partially denaturing urea gels, which is furthermore consis-
tent with the inhibition of vRNA synthesis by nonhydrolyz-
able analogs of ATP (data not shown) and implies that
ATPase and/or helicase unwinding functions may contrib-
ute to replicase activity (Grassman et al., 1999). Replicase
activity is membrane-dependent as inclusion of NaDOC
(0.1–2%) results in a reduction of vRNA but not RI/RF
synthesis and sensitivity of endogenous RNA template to
nucleases (data not shown). Similarly, NaDOC blocks ini-
tiation of vRNA but not elongation of RI and RF RNA by
membrane fractions containing poliovirus replication com-
plexes (Egger et al., 1996).
The asymmetry of BVDV RNAs observed in the isolated
complex is conserved in the in vitro reaction. Routinely, a
4.7-fold increase in the amount of positive strand and a
2-fold increase in negative strand RNA are detected during
a 60-min reaction by quantitative RPA. The probes used to
quantitate product RNA hybridize to the 3 ends of full-
length BVDV RNAs and hence may underestimate the
actual product yield. Indeed, a greater amount of RNA
Fig. 5. Time course and pulse chase labeling of replicase reaction. (A) RNA products were purified at the indicated times following synthesis by CRC
replicase (6.25  105 ceq) isolated from mock and BVDV infected cells in the presence of [32P]CTP. RNA was electrophoresed on a 3% PAGE–7 M urea
gel. Positions of RI, vRNA (12.5 kb), and RF are indicated. (B) RNA products on the gel were quantitated by phosphorimager analysis and plotted per time.
(C) RNA products were purified from a reaction which was initiated with unlabeled NTPS and then pulsed by the addition of [32P]CTP at 5, 10, 20, 30, 40
and 60 min for a 20-min period. Transcripts were electrophoresed on a 3% PAGE–7 M urea gel and autoradiographed. (D) RNA products on the gel were
quantitated by phosphorimager analysis and plotted per time.
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products are detected by Northern blot using probes which
hybridize to the 5 ends of the positive and negative strand
RNAs relative to probes which recognize the 3 ends, sig-
nifying that short transcripts are also initiated (Fig. 3B and
C). Approximately 24,500 and 800 copies of positive and
negative strand RNA products are synthesized, respectively,
during a 60-min reaction, which is reasonable considering
that six to seven nascent strands of RNA can be made per
BVDV RI molecule in infected cells (Gong et al., 1998) and
that recycling and reinitiation from the RI appear to take
place in this system.
Kinetic experiments demonstrate the sequential synthesis
of product RNAs and the recycling of RF and RI as template
and precursor, respectively, during the in vitro synthesis of
BVDV vRNA. Initially, the greatest product labeling occurs
in the RI as nascent vRNA transcripts are elongated, and
then plateaus concomitant with the release of vRNA from
the intermediate and the generation of RF product. A sig-
nificant accumulation of dsRF occurs which can be attrib-
uted to either the synthesis of negative strand RNA or the
recycling of RF from RI as a dead-end product containing
transcripts that are not displaced from the negative strand
template. However, the limited amount of negative strand
RNA synthesis which occurs in this system indicates that
minimal dsRF can be formed by complementary synthesis.
On the other hand, RF cannot be solely a dead-end product,
since pulse labeling indicates the continuous synthesis of RI
and vRNA throughout the reaction, whereas RF decreases
significantly over time. Consistent with this, the ratio of
pulse labeled RI to RF at 60 min is 2- to 3-fold larger than
Fig. 6. Effect of heparin on BVDV replicase activity. RNA products were synthesized at the indicated times in the in vitro BVDV replicase assay (6.25 
105 ceq) in the absence or presence of added heparin (2 mg/ml). (A) RNA products were electrophoresed on a 3% PAGE–7 M urea gel. (B) RNA products
on the gel were quantitated by phosphorimager analysis and plotted per time.
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that observed earlier in the reaction. Taken together, our
results indicate that RI is maintained in equilibrium as a
precursor for additional rounds of vRNA synthesis, sup-
ported by a partial recycling of RF as a template. However,
the greater linear rate of RF labeling compared to that of RI
and the overall decrease in pulse labeling of all products
over time indicates that a limited amount of initiation occurs
in this system, in line with the modest increases in RNA
synthesis that are measured by RPA, Northern, and PCR
analyses. These observations are somewhat similar to those
reported for the replication of Kunjin Flavivirus RNA (Chu
and Westaway, 1985, 1987).
Heparin trapping of the replicase complexes confirms
that the initiation of RNA synthesis takes place in this
system. In the presence of heparin, the synthesis of all
BVDV RNA products is inhibited, indicating that reinitia-
tion by replication complexes is prevented. The most pro-
nounced heparin effect is observed upon vRNA synthesis
and at 60 min, when synthesis is greatest, a maximum
inhibition of 65% is attained, indicating that at least a
portion of the replicase complexes are available to initiate
new rounds of vRNA replication. However, it can not be
ascertained from these experiments whether initiation is
attributed to replication complexes which reinitiate synthe-
sis following the completion of nascent RNA strands or the
presence of additional replicase complexes in the isolated
fraction. The heparin-induced buildup of RI and RF prod-
ucts observed early in the reaction is likely due to an
absence of initiation which is required for strand displace-
ment and subsequent vRNA turnover, further substantiating
that initiation takes place.
The potential relevance of the in vitro replicase system to
in vivo replication is additionally provided by the finding
that a triazinoindole compound, previously reported to in-
hibit BVDV replication, inhibits the in vitro synthesis of
RNA by BVDV replicase complexes with a potency similar
to that observed in infected cells (Baginski et al., 2000).
This is a striking result given that the previously reported
IC50 for recombinant BVDV NS5b polymerase was 10-fold
less than that obtained in infected cells (Baginski et al.,
2000). We likewise observe that the inhibition of BVDV
NS5b polymerase activity is 10-fold less compared to that
of a single cycle infectivity assay. The equivalent sensitiv-
ities demonstrated by the replicase and viral infectivity
assays indicate that the antiviral effect is attributed to the
inhibition of RNA synthesis catalyzed by replication com-
plexes in infected cells and that the replicase activity is an
in vitro correlate of replication in cells. Additionally, the
more pronounced effect of the inhibitor upon replicase in
comparison to NS5B activity may reflect fundamental dif-
ferences in the function of NS5b in the context of membrane
complexes and/or the mode of action of the inhibitor.
Overall, BVDV replicase complexes isolated from in-
fected cells exhibit properties of RNA synthesis which are
hallmarks for the positive strand RNA viruses, typified by
the asymmetric synthesis of product RNAs, the recycling of
replicative intermediates, and the initiation of RNA synthe-
sis. Clearly, more work is necessary to establish the func-
tional contributions of the individual nonstructural proteins
to replicative activity and the mechanism(s) involved in the
initiation of RNA synthesis. Nonetheless, the in vitro sys-
tem described here offers the propensity to study replicase
activity isolated in its native state from infected cells which
will aid in mechanistic studies and in the characterization of
inhibitors of Flaviviridae replication.
Materials and methods
Compound 1, 3-[((2-dipropylamino)ethyl)thio]-5h-[1,2,4]-
triazino[5,6-b]indole, was synthesized according to that previ-
ously described (Gladych et al., 1972).
Fig. 7. Inhibition of BVDV replicase activity. (A) Compound 1 was added
at the indicated concentrations to the in vitro BVDV replicase reaction
(3.12  105 ceq) and then the RNA products were purified and electro-
phoresed on a 0.7% agarose–glyoxal denaturing gel. RNA products were
quantitated by phosphorimager analysis and the IC50 was determined as
described under Materials and methods. (B) Summary of the IC50 of
compound 1 determined in the BVDV replicase, BVDV infectivity, and
BVDV NS5b assays as described under Materials and methods.
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Isolation of CRC and PNS fractions from infected MDBK
cells
Cells (MDBK) at 85% confluency were infected with or
without BVDV (NADL) at MOIs ranging from 0.1 to 2.0
and incubated at 37°C, 5% CO2, until 75% CPE was ob-
served in monolayers. Routinely, cells were infected at an
MOI of 0.1 for 48 hr and replicase complexes were isolated
by modification of previously described procedures (Grun
and Brinton, 1986; Takegami et al., 1983). Briefly, cells
were scraped and washed in cold phosphate-buffered saline,
pelleted by centrifugation at 800g for 5–10 min at 4°C, and
then swelled in ice-cold hypotonic lysis buffer (10 mM
Tris–HCl, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM
PMSF, 2 g/ml aprotinin) at 5 107 cells/ml for 10 min on
ice prior to Dounce homogenization (25 strokes). Nuclei
were pelleted from the homogenate at 1000g for 5 min at
4°C and the cytoplasmic extract was centrifuged at 30,000g
for 25 min at 4°C to pellet the crude replication complexes,
which were then resuspended in membrane resuspension
buffer (10 mM Tris–Cl, pH 8.0, 10 mM NaCl, 15% glyc-
erol) at 2.5  105 cell equivalent/l, ca. 2.3 mg/ml total
protein by Bradford assay (Bio-Rad, Inc.), and stored at
70°C. The perinuclear supernatant was obtained by shear-
ing of nuclei resusupended in buffer [10 mM Tris–Cl, pH
8.0, 10 mM NaCl] at 1.25  105 ceq/l, six times each in
20- and 26-gauge needles, and then clarified at 1000g for 10
min, 4°C, and stored at 70°C.
Replicase assay
Indicated amounts (3.1  105–1.25  106 ceq) of CRC
or PNS fractions were incubated in a reaction containing 50
mM Hepes, pH 8.0, 3.5 mM magnesium acetate, 10 mM
DTT, 50 mM KCl, and 1 mM each of A, G, and UTP, 10
M CTP, and 10 Ci 32P-CTP [3000 Ci/mMole], RNasin,
2.5 mM phosphoenol pyruvate, 0.7 units pyruvate kinase,
and 40 g/ml act D at 35°C for the indicated times. RNA
was phenol extracted, ethanol precipitated, and then heat
denatured in glyoxal sample buffer (Ambion, Inc.) at 55°C
for 45 min and electrophoresed on 0.7% agarose–glyoxal
denaturing gels or was partially denatured in 1X sample
buffer and electrophoresed on 3% PAGE–7 M urea gels as
described previously (Chu and Westaway, 1985). Alterna-
tively, purified RNA products were hybridized to cDNA
probes immobilized on a nitrocellulose filter and quantitated
by phosphorimager analysis or TCA precipitated on glass
fiber filters and quantitated by liquid scintillation counting.
Compound 1, DMSO, or heparin was added for 5 min to the
enzyme reaction prior to initiation with NTPs when indi-
cated. Inhibitory concentration 50% (IC50) was determined
as a percentage of the DMSO control by fitting the data to
a four-parameter fit function using Kaleidagraph software
(Synergy Software, Reading, PA).
RNase protection assay
RNA products synthesized in reactions containing CRC
replicase (1.25  106 ceq) isolated from mock or BVDV
infected MDBK cells in the absence of [32P]-CTP at 0 or 60
min were purified by phenol extraction and ethanol precip-
itation and then subjected to RNase protection using an
RPA kit II, according to the manufacturer’s protocol (Am-
bion, Inc.). Probes were prepared by runoff transcription in
the presence of [32P]-UTP from the 5 NTR for the sense
probe and from the 3 NTR for the antisense probe, gel
purified, and hybridized to RNA overnight at 37°C. Hybrids
were digested with RNase A/T1 for 30 min at 37°C. Fol-
lowing precipitation, the products were electrophoresed on
5% PAGE–8 M urea gels and quantitated by phosphorim-
ager analysis.
Western blot analysis
Proteins were electrophoresed on 10% Bis–-Tris Nupage
(Novex) gels in MES or Mops buffer and then transferred
onto PVDF membranes. Membranes were blocked in PBS
containing 1.5% Tween 200 and 3% BSA and then incu-
bated with appropriate antisera diluted in wash buffer, PBS
containing 0.1% Tween 20 for 1–2 h at RT, washed exten-
sively, and then incubated with HRP-conjugated antibody
provided with ECL (Amersham) kit reagents. Blots were
processed with ECL kit reagents and autoradiographed.
Anti-peptide antisera were generated in rabbits by N-termi-
nal cysteine coupling to KLH (Zymed, Inc.): anti-NS2 (No.
1541–1560), anti-NS3 (No. 2296–2309), anti-NS4A (No.
2397–2422), anti-NS4B (2546–2562); anti-NS5B (No.
3837–3849).
Northern blot analysis
RNA was purified by phenol extraction and ethanol pre-
cipitation from CRC replicase reactions (1.25  106c eq) at
various times and then electrophoresed on 0.7% agarose–
glyoxal denaturing gels. RNA was transferred onto nylon
membranes, blotted, and probed according to the manufac-
turer’s protocol using the Northern Max-Gly kit (Ambion,
Inc.) with 32P-labeled NS5b sense or antisense RNA probes
(1–2  106 cpm/ml). Blots were quantitated by phospho-
rimager analysis.
LiCl precipitation and RNase sensitivity assays
LiCl precipitation and RNase sensitivity assays were
performed as previously described (Behrens, et al., 1996;
Chu and Westaway, 1985). Briefly, purified replicase prod-
ucts were treated with 2 M LiCl overnight at 4°C and then
pelleted at 17,000g. Precipitates were resuspended in a
volume equivalent to the supernatant fraction and the RNA
was ethanol precipitated from both fractions and then elec-
trophoresed on a 3% PAGE–7 M urea gel as described
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previously (Chu and Westaway, 1985). Where indicated,
products were digested with RNase A/T1 in high salt (500
mM NaCl) or low salt (50 mM NaCl) in 10 mM Tris–Cl, pH
7.5, 5 mM EDTA) for 20 min at 37°C and ethanol precip-
itated prior to electrophoresis (Behrens et al., 1996).
BVDV infectivity assay
Compound or DMSO was added to MDBK cells grow-
ing in 96-well cytostar plates at 80% confluency and were
then infected at an MOI of 0.3 with the NADL strain for
24 h. Medium was removed and cells were fixed in forma-
lin, permeabilized with 0.25% Triton X-100 in PBS for 20
min at room temperature, and then hybridized overnight at
50°C with an anti-sense, 33P-labeled probe (1  106 cpm),
transcribed from the BVDV 3 NTR. Plates were washed
and then treated with RNAse A (20 g/ml) in RNase A
buffer at room temperature for 30 min and then washed in
0.25  SSC/well at 65°C/20 min and counted in a Top-
Count (Packard, Inc.).
BVDV NS5b polymerase assay
BVDV NS5B protein was purified according to the
method described previously (Carroll et al., 2000) from
Sf21 cell pellets following expression of full-length BVDV
NS5B protein (NADL) in a Baculovirus vector. RNA-de-
pendent RNA polymerase activity was assayed in a total
volume of 50 L and was measured as the incorporation of
[-32P]GTP using the RNA template (t500) as described.
Compound or DMSO were added to a reaction mix con-
taining enzyme and template was added and then initiated
by the addition of a mixture of NTPs (1 M GTP, 500 M
ATP, UTP, CTP) and incubated at 37°C. Reactions were
quenched 20 L of 0.5 M EDTA, and product formation
was determined by DE-81 filter binding (Whatman) as pre-
viously described (Carroll et al., 2000).
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